Under the terms of the LOI and proposed Agreement, Namaste will hold exclusive rights to research and distribute Inolife’s needle-free injection technologies for applications in the cannabis industry. Namaste will also participate in Inolife’s anticipated private placement by acquiring up to 10% of the … Read More
The post Namaste Announces LOI With Inolife R&D to Conduct a Research Study to Evaluate Needle-Free … appeared first on Dagga Magazine.